20 results
DEFR14A
esohqmutthb39tqjpar2
12 May 22
Revised proxy
5:00pm
8-K
EX-14.1
8rlsetify 1lijwdtdwt
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
EX-10.1
sodsjs
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
0i5d971526knz9fb8g3
16 Mar 20
Annual report
11:09am
8-K
EX-10.1
6efpckgj0ary pwu
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
y8igtp
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
a3lpquj tm
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-10.1
qze7254
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
424B3
8a9g7 7rpinup8n
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
j84ridw03nxu ke3
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
fesacjsagitx6b7 eck1
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next